Figure 4 | Scientific Reports

Figure 4

From: SEPROGADIC – serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy

Figure 4

Kaplan-Meier plots of MD panel in SEPROGADIC-AT selection module. (a) AT module scores at the three endpoints in the CCRT group (n = 120) and CTX group (n = 107). Patients are divided into four subgroups (true CCRT, false CCRT, true CTX and false CTX) based on the median of AT scores. NR: no recurrence, C: censored, R: recurrence. (b) K-M plots of four subtypes. True CCRT (n = 63; observed: 3), false CCRT (n = 57; observed: 14), true CTX (n = 56; observed: 7), false CTX (n = 51; observed: 20).

Back to article page